These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38032469)

  • 21. Identification of a Novel Ferroptosis-Related Gene Prediction Model for Clinical Prognosis and Immunotherapy of Colorectal Cancer.
    Yang YB; Zhou JX; Qiu SH; He JS; Pan JH; Pan YL
    Dis Markers; 2021; 2021():4846683. PubMed ID: 34868393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active Enhancer Assessment by H3K27ac ChIP-seq Reveals Claudin-1 as a Biomarker for Radiation Resistance in Colorectal Cancer.
    Chen ZX; Huang HQ; Wen JY; Qin LS; Song YD; Fang YY; Zeng DT; Huang WJ; Qin XG; Gan TQ; Luo J; Li JJ
    Dose Response; 2021; 19(4):15593258211058981. PubMed ID: 34987334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal MEF2C's Association With the Progression of CRC in Regulating CD36 Transcription.
    Wang M; Jiang Y; Fan ZL; Zhang N; Liang J; Zheng Z
    Altern Ther Health Med; 2023 Jan; 29(1):198-209. PubMed ID: 36074971
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-cell transcriptome analysis reveals tumor immune microenvironment heterogenicity and granulocytes enrichment in colorectal cancer liver metastases.
    Zhang Y; Song J; Zhao Z; Yang M; Chen M; Liu C; Ji J; Zhu D
    Cancer Lett; 2020 Feb; 470():84-94. PubMed ID: 31610266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
    Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
    BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ferroptosis-related Genes for Overall Survival Prediction in Patients with Colorectal Cancer can be Inhibited by Gallic acid.
    Hong Z; Tang P; Liu B; Ran C; Yuan C; Zhang Y; Lu Y; Duan X; Yang Y; Wu H
    Int J Biol Sci; 2021; 17(4):942-956. PubMed ID: 33867820
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of candidate biomarkers and therapeutic drugs of colorectal cancer by integrated bioinformatics analysis.
    Zheng Z; Xie J; Xiong L; Gao M; Qin L; Dai C; Liang Z; Wang Y; Xue J; Wang Q; Wang W; Li X
    Med Oncol; 2020 Oct; 37(11):104. PubMed ID: 33078282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KLF2 inhibits colorectal cancer progression and metastasis by inducing ferroptosis via the PI3K/AKT signaling pathway.
    Li J; Jiang JL; Chen YM; Lu WQ
    J Pathol Clin Res; 2023 Sep; 9(5):423-435. PubMed ID: 37147883
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal model and bioinformatics analyses suggest the TIMP1/MMP9 axis as a potential biomarker in oral squamous cell carcinoma.
    Xu G; Wei J; Huangfu B; Gao J; Wang X; Xiao L; Xuan R; Chen Z; Song G
    Mol Carcinog; 2020 Nov; 59(11):1302-1316. PubMed ID: 33006223
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrative Gene Expression Profiling Analysis to Investigate Potential Prognostic Biomarkers for Colorectal Cancer.
    Liu X; Bing Z; Wu J; Zhang J; Zhou W; Ni M; Meng Z; Liu S; Tian J; Zhang X; Li Y; Jia S; Guo S
    Med Sci Monit; 2020 Jan; 26():e918906. PubMed ID: 31893510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [High expression of fragile X mental retardation protein inhibits ferroptosis of colorectal tumor cells by activating the RAS/MAPK signaling pathway].
    Wang N; Shi B; Man X; Wu W; Cao J
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):885-893. PubMed ID: 38862446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1.
    Liu D; Wang W; Wu Y; Qiu Y; Zhang L
    Curr Cancer Drug Targets; 2024; 24(5):519-533. PubMed ID: 38804344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anoikis-related gene signatures in colorectal cancer: implications for cell differentiation, immune infiltration, and prognostic prediction.
    Ding T; Shang Z; Zhao H; Song R; Xiong J; He C; Liu D; Yi B
    Sci Rep; 2024 May; 14(1):11525. PubMed ID: 38773226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Ferroptosis-Related Hub Genes and Their Association with Immune Infiltration in Chronic Obstructive Pulmonary Disease by Bioinformatics Analysis.
    Yang YC; Zhang MY; Liu JY; Jiang YY; Ji XL; Qu YQ
    Int J Chron Obstruct Pulmon Dis; 2022; 17():1219-1236. PubMed ID: 35637927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apolipoprotein L3 enhances CD8+ T cell antitumor immunity of colorectal cancer by promoting LDHA-mediated ferroptosis.
    Lv Y; Tang W; Xu Y; Chang W; Zhang Z; Lin Q; Ji M; Feng Q; He G; Xu J
    Int J Biol Sci; 2023; 19(4):1284-1298. PubMed ID: 36923931
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction and Validation of Hub Genes Associated with Colorectal Cancer by Integrating PPI Network and Gene Expression Data.
    Xiong Y; You W; Wang R; Peng L; Fu Z
    Biomed Res Int; 2017; 2017():2421459. PubMed ID: 29209625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. USP11-mediated LSH deubiquitination inhibits ferroptosis in colorectal cancer through epigenetic activation of CYP24A1.
    Duan J; Huang D; Liu C; Lv Y; Zhang L; Chang F; Zeng X; Li L; Wang W; Shao G
    Cell Death Dis; 2023 Jul; 14(7):402. PubMed ID: 37414755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CircRNA circSTIL inhibits ferroptosis in colorectal cancer via miR-431/SLC7A11 axis.
    Li Q; Li K; Guo Q; Yang T
    Environ Toxicol; 2023 May; 38(5):981-989. PubMed ID: 36840697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploration of key ferroptosis-related genes and immune infiltration in Crohn's disease using bioinformatics.
    Tang X; Hu W; You W; Fang T
    Sci Rep; 2023 Aug; 13(1):12769. PubMed ID: 37550393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation.
    Chen P; Li X; Zhang R; Liu S; Xiang Y; Zhang M; Chen X; Pan T; Yan L; Feng J; Duan T; Wang D; Chen B; Jin T; Wang W; Chen L; Huang X; Zhang W; Sun Y; Li G; Kong L; Chen X; Li Y; Yang Z; Zhang Q; Zhuo L; Sui X; Xie T
    Theranostics; 2020; 10(11):5107-5119. PubMed ID: 32308771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.